Loading...
•
Sep 30, 2021
HCA Q3 2021 Earnings Report
HCA Healthcare's financial performance surged in Q3 2021, marked by revenue growth and significant gains from facility sales.
Key Takeaways
HCA Healthcare reported a strong third quarter in 2021 with revenues of $15.276 billion and net income of $2.269 billion, driven by increased patient volumes and gains on sales of facilities, despite the challenges posed by the Delta variant.
Revenues increased to $15.276 billion, compared to $13.311 billion in Q3 2020.
Net income attributable to HCA Healthcare, Inc. was $2.269 billion, or $7.00 per diluted share, compared to $668 million, or $1.95 per diluted share, in Q3 2020.
Adjusted EBITDA totaled $3.224 billion, compared to $2.053 billion in Q3 2020.
Same facility admissions and equivalent admissions increased by 6.8% and 9.3%, respectively.
Forward Guidance
HCA Healthcare revised its 2021 guidance, projecting revenues between $58.7 to $59.3 billion and adjusted EBITDA between $12.50 to $12.80 billion.
Positive Outlook
- Revenue is expected to be between $58.7 to $59.3 billion.
- Adjusted EBITDA is projected to be $12.50 to $12.80 billion.
- Diluted EPS is anticipated to be between $17.20 to $17.80.
- Capital expenditures are estimated to be approximately $3.7 billion.
- The guidance reflects current expectations regarding the impact of the COVID-19 pandemic and related government legislation.
Challenges Ahead
- Guidance excludes the impact of items such as gains or losses on sales of facilities.
- Guidance excludes the impact of losses on retirement of debt.
- Guidance excludes the impact of legal claims costs.
- Guidance excludes the impact of impairment of long-lived assets.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...